Australian regulator TGA warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic
Australia's Therapeutic Goods Administration (TGA) has issued warnings for GLP-1 drugs including Ozempic and Mounjaro due to a link with NAION, a rare but severe eye disorder that can cause blindness. The warning follows 36 reported cases of the condition associated with these diabetes and weight loss medications. Product information for affected drugs has been updated to include this potential risk.
1 Article
Trace's outlet lean is shown first — tap Left / Center / Right on each source to add your rating too.
- The GuardianTrace: Left
Australian regulator TGA warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic
Australia's Therapeutic Goods Administration (TGA) has issued warnings for GLP-1 drugs including Ozempic and Mounjaro due to a link with NAION, a rare but severe eye disorder that can cause blindness. The warning follows 36 reported cases of the condition associated with these diabetes and weight loss medications. Product information for affected drugs has been updated to include this potential risk.
Rate outletRead original